Cargando…
OR21-03 Determining Novel Therapeutic Targets Using an in Vitro Model of TRb Tumor Suppression in Anaplastic Thyroid Cancer
Anaplastic thyroid cancer (ATC) is one of the most lethal endocrine cancers, with an average survival time of six months after diagnosis. These aggressive tumors are characterized by rapid local extension, distant metastasis, and resistance to radioactive iodine therapy and mainstream chemotherapy....
Autores principales: | Gillis, Noelle E, Bolf, Eric L, Davidson, Cole, Cozzens, Lauren, Tomczak, Jennifer, Lian, Jane B, Frietze, Seth, Carr, Frances E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208428/ http://dx.doi.org/10.1210/jendso/bvaa046.1892 |
Ejemplares similares
-
SAT-571 Restoration of Thyroid Hormone Receptor Beta Signaling Reprograms Anaplastic Thyroid Cancer Cells
por: Gillis, Noelle, et al.
Publicado: (2019) -
SAT-573 Characterization of the Gene Expression Program of a Mutant Thyroid Hormone Receptor in Anaplastic Thyroid Cancer
por: Bolf, Eric, et al.
Publicado: (2019) -
Thyroid Hormone Receptor Beta Inhibits PI3K-Akt-mTOR Signaling Axis in Anaplastic Thyroid Cancer via Genomic Mechanisms
por: Davidson, Cole D, et al.
Publicado: (2021) -
Thyroid hormone dependent transcriptional programming by TRβ requires SWI/SNF chromatin remodelers
por: Gillis, Noelle E, et al.
Publicado: (2022) -
Cardiac Metastasis From Anaplastic Thyroid Carcinoma
por: Gonzalez, Michelle N Garcia, et al.
Publicado: (2021)